Alpa Laboratories Limited Stock Price Today (NSE: ALPA)
Fundamental Score
Alpa Laboratories Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Alpa Laboratories Limited share price today is ₹61.12, up +1.21% on NSE/BSE as of 16 September 2026. Alpa Laboratories Limited (ALPA) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹128.60 (Cr). The 52-week high for ALPA share price is ₹96.80 and the 52-week low is ₹46.10. At a P/E ratio of 36.38x, ALPA is currently trading above its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 8.39% and a debt-to-equity ratio of 0.01.
Alpa Laboratories Limited Share Price Chart — NSE/BSE Historical Performance
Alpa Laboratories Limited share price chart: -9.09% return over the past month. 52-week high ₹96.80, 52-week low ₹46.10.
Alpa Laboratories Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹60.06 | ₹64.50 | ₹59.40 | ₹61.12 | 14.77K (Cr) | |
| ₹62.00 | ₹62.80 | ₹60.00 | ₹60.39 | 10.74K (Cr) | |
| ₹62.93 | ₹63.20 | ₹61.00 | ₹61.69 | 10.63K (Cr) | |
| ₹63.24 | ₹64.02 | ₹62.19 | ₹62.62 | 8.80K (Cr) | |
| ₹63.80 | ₹64.40 | ₹62.49 | ₹63.24 | 24.55K (Cr) | |
| ₹62.00 | ₹65.00 | ₹61.70 | ₹63.17 | 28.76K (Cr) | |
| ₹63.99 | ₹63.99 | ₹61.50 | ₹62.17 | 3.39K (Cr) | |
| ₹64.00 | ₹64.00 | ₹61.50 | ₹62.71 | 9.19K (Cr) | |
| ₹63.79 | ₹64.60 | ₹63.05 | ₹63.30 | 5.83K (Cr) | |
| ₹61.73 | ₹65.00 | ₹61.35 | ₹63.13 | 18.73K (Cr) |
Alpa Laboratories Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹63.90 | ₹65.00 | ₹59.40 | ₹61.12 | -4.35% | |
| ₹67.55 | ₹72.50 | ₹60.05 | ₹62.73 | -7.14% | |
| ₹69.20 | ₹78.89 | ₹65.00 | ₹66.84 | -3.41% | |
| ₹72.50 | ₹73.69 | ₹66.61 | ₹67.55 | -6.83% | |
| ₹66.17 | ₹74.80 | ₹66.09 | ₹71.42 | +7.93% | |
| ₹50.65 | ₹72.47 | ₹48.60 | ₹66.18 | +30.66% | |
| ₹66.80 | ₹66.80 | ₹46.10 | ₹46.46 | -30.45% | |
| ₹68.01 | ₹76.18 | ₹64.40 | ₹66.01 | -2.94% | |
| ₹77.85 | ₹80.08 | ₹61.00 | ₹68.14 | -12.47% | |
| ₹78.60 | ₹92.50 | ₹75.00 | ₹77.69 | -1.16% | |
| ₹90.20 | ₹91.86 | ₹75.55 | ₹78.16 | -13.35% | |
| ₹90.00 | ₹93.85 | ₹85.91 | ₹91.57 | +1.74% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Alpa Laboratories Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Alpa Laboratories Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ALPA across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Robust Profit Growth (165.09%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (25.22%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Strong Profit Growth Track Record (23.66% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.01)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (65.72x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Healthy Liquidity Position (Current Ratio: 4.10)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Balanced Promoter Holding (57.29%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
5 factors identified
Below-Average Return on Equity (8.39%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (9.28%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Limited Growth History (1.64% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Limited Institutional Interest (FII+DII: 0.38%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Alpa Laboratories Limited vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Alpa Laboratories Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Alpa Laboratories LimitedAlpa Laboratori...Selected✓ ALPA • 532878 | 60.3/100 | ₹61.12₹61 | ₹128.60₹128.60 | 36.38Average 36.4 Average | 8.39%Poor 8.39% Poor | 9.28%Poor 9.28% Poor | 0.01Excellent 0.0 Excellent | 23.66%Excellent 23.66% Excellent | 1.64%Average 1.64% Average | 0.00% |
Sun Pharmaceutical Industries LimitedSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1840.00₹1840 | ₹441471.20₹441471.20 | 36.51Average 36.5 Average | 14.74%Average 14.74% Average | 19.31%Good 19.31% Good | 0.05Excellent 0.0 Excellent | 31.64%Excellent 31.64% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divi's Laboratories LimitedDivi's Laborato... DIVISLAB • 532488 | 56.3/100 | ₹9322.00₹9322 | ₹247033.00₹247033.00 | 84.58Average 84.6 Average | 16.19%Good 16.19% Good | 20.38%Excellent 20.38% Excellent | 0.00Excellent 0.0 Excellent | 5.29%Good 5.29% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LimitedTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹4965.50₹4966 | ₹168062.31₹168062.31 | 79.32Average 79.3 Average | 27.07%Excellent 27.07% Excellent | 14.09%Average 14.09% Average | 1.76Average 1.8 Average | 11.56%Good 11.56% Good | 11.80%Good 11.80% Good | 0.76% |
Zydus Lifesciences LimitedZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1119.10₹1119 | ₹111686.18₹111686.18 | 24.94Average 24.9 Average | 19.74%Good 19.74% Good | 21.77%Excellent 21.77% Excellent | 0.43Excellent 0.4 Excellent | 18.76%Excellent 18.76% Excellent | 12.45%Good 12.45% Good | 0.09% |
Cipla LimitedCipla Limited... CIPLA • 500087 | 40.2/100 | ₹1366.00₹1366 | ₹110352.31₹110352.31 | 32.73Average 32.7 Average | 11.82%Average 11.82% Average | 15.67%Good 15.67% Good | 0.01Excellent 0.0 Excellent | 10.03%Good 10.03% Good | 8.01%Good 8.01% Good | 0.90% |
Laurus Labs LimitedLaurus Labs Lim... LAURUSLABS • 540222 | 34.1/100 | ₹1969.00₹1969 | ₹106375.23₹106375.23 | 97.19Average 97.2 Average | 18.19%Good 18.19% Good | 21.35%Excellent 21.35% Excellent | 0.45Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Dr. Reddy's Laboratories LimitedDr. Reddy's Lab... DRREDDY • 500124 | 41/100 | ₹1165.50₹1166 | ₹97319.25₹97319.25 | 30.12Average 30.1 Average | 11.75%Average 11.75% Average | 14.80%Average 14.80% Average | 0.17Excellent 0.2 Excellent | 16.54%Excellent 16.54% Excellent | 12.09%Good 12.09% Good | 0.65% |
Aurobindo Pharma LimitedAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1679.80₹1680 | ₹96655.69₹96655.69 | 26.25Average 26.2 Average | 9.94%Poor 9.94% Poor | 14.54%Average 14.54% Average | 0.20Excellent 0.2 Excellent | -8.07%Poor -8.07% Poor | 6.32%Good 6.32% Good | 0.26% |
Lupin LimitedLupin Limited... LUPIN • 500257 | 83.4/100 | ₹2095.00₹2095 | ₹95793.88₹95793.88 | 17.31Average 17.3 Average | 26.90%Excellent 26.90% Excellent | 31.80%Excellent 31.80% Excellent | 0.26Excellent 0.3 Excellent | 34.39%Excellent 34.39% Excellent | 13.02%Good 13.02% Good | 0.72% |
Mankind Pharma LimitedMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2280.00₹2280 | ₹94164.00₹94164.00 | 46.07Average 46.1 Average | 12.49%Average 12.49% Average | 13.56%Average 13.56% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Limited share price441471.20 Cr
- Divi's Laboratories Limited share price247033.00 Cr
- Torrent Pharmaceuticals Limited share price168062.31 Cr
- Zydus Lifesciences Limited share price111686.18 Cr
- Cipla Limited share price110352.31 Cr
Alpa Laboratories Limited PE Ratio History
Historical price-to-earnings ratio for ALPA — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹8.01 | ₹118.46 | 14.8x |
| FY 2023 | ₹5.88 | ₹103.30 | 17.6x |
| FY 2022 | ₹6.70 | ₹63.00 | 9.4x |
| FY 2021 | ₹3.45 | ₹79.40 | 23x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Alpa Laboratories Limited Quarterly Performance
Latest quarterly metrics for ALPA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
25.22%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
165.09%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
1.64%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
23.66%
Compounded annual net profit growth over 5 years
Alpa Laboratories Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ALPA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Alpa Laboratories Limited Financial Statements
Annual income statement, balance sheet and cash flow for Alpa Laboratories Limited (ALPA) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Alpa Laboratories Limited
About ALPA (Alpa Laboratories Limited)
Alpa Laboratories Ltd is a dynamic pharmaceutical company rooted in Indore, India, dedicated to the development, manufacturing, and distribution of a diverse range of pharmaceutica...l products. With a history stretching back to its incorporation, the company has steadily cultivated a reputation for quality and reliability within the Indian pharmaceutical landscape. Alpa Laboratories focuses on providing accessible and effective medications, aiming to cater to a broad spectrum of healthcare needs across various therapeutic areas. Their commitment to rigorous quality control and adherence to industry best practices ensures that their products meet the highest standards of safety and efficacy, solidifying their position as a trusted provider in the market. The company's enduring presence speaks to its commitment to innovation and service within the ever-evolving healthcare sector. Alpa Laboratories is characterized by its dedication to producing formulations that cover a wide range of therapeutic segments. This encompasses areas such as pain management, cardiovascular health, and anti-infectives, showcasing the company's breadth and ability to address numerous prevalent health concerns. The company demonstrates an understanding of the healthcare challenges facing India and strives to provide solutions through its comprehensive product portfolio. This diverse offering allows Alpa Laboratories to serve a broad patient base and contribute meaningfully to improved healthcare outcomes across the country. The firm's commitment to expanding its therapeutic reach underscores its ambition to be a significant contributor to the health and well-being of the Indian population. At its core, Alpa Laboratories operates with a vision of enhancing patient lives through access to quality pharmaceuticals. While firmly established in Indore, the company's influence extends across India, reaching patients and healthcare providers alike. Their established infrastructure and distribution network enable them to effectively deliver their products to various markets, ensuring accessibility and timely availability. Alpa Laboratories' steady growth trajectory reflects its focus on sustainable practices, continuous improvement, and a dedication to meeting the evolving needs of the healthcare industry. This unwavering commitment to excellence positions Alpa Laboratories for continued success and growth in the years to come.
Company Details
Key Leadership
ALPA Share Price: Frequently Asked Questions
What is the current share price of Alpa Laboratories Limited?
Alpa Laboratories Limited (ALPA) trades at ₹61.12 on NSE and BSE. Market cap ₹128.60 (Cr). Educational data only.
What is the P/E ratio of Alpa Laboratories Limited?
Alpa Laboratories Limited has a P/E of 36.38x vs industry average 34.89x.
What is the Bull Run score for Alpa Laboratories Limited?
Alpa Laboratories Limited has a Bull Run score of 60.3/100 based on 25+ financial parameters.
Does Alpa Laboratories Limited pay dividends?
Alpa Laboratories Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Alpa Laboratories Limited?
Alpa Laboratories Limited has ROE of 8.39%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Alpa Laboratories Limited?
Alpa Laboratories Limited has debt-to-equity of 0.01.
Is Alpa Laboratories Limited a good investment?
Bull Run gives Alpa Laboratories Limited a score of 60.3/100. This is not investment advice — consult a SEBI-registered advisor.